Indication
Withdrawal
2 clinical trials
4 products
Clinical trial
Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal: A Prospective Cohort StudyStatus: Completed, Estimated PCD: 2024-02-15
Product
ClonidineClinical trial
A Prospective Phase II Clinical Trial Evaluating the Efficacy and the Safety of Tyrosine Kinase Inhibitors Withdrawal After a Previous Two-step Dose Reduction in Patients With Chronic Myeloid Leukemia in Deep Molecular RemissionStatus: Active (not recruiting), Estimated PCD: 2026-06-01
Product
ImatinibProduct
DasatinibProduct
Nilotinib